Curcumin suppression of cytokine release and cytokine storm. A potential therapy for patients with Ebola and other severe viral infections

In Vivo

Volumn 29, Issue 1, 2015, Pages 1-4

  Sordillo, Peter P ^a   Helson, Lawrence ^a  

^a SignPath Pharma Inc   (United States)

Author keywords

Curcumin; Cytokine storm; Ebola; Interleukin 1; Interleukin 6; Review; Tumor necrosis factor

Indexed keywords

CURCUMIN; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 1; SUPPRESSOR OF CYTOKINE SIGNALING; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONVALESCENCE; CYTOKINE RELEASE; CYTOKINE STORM; DISEASE COURSE; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG MECHANISM; EBOLA HEMORRHAGIC FEVER; HUMAN; IMMUNE SYSTEM; MORTALITY; NONHUMAN; PHARMACEUTICAL CARE; VIRUS INFECTION; ANIMAL; BIOSYNTHESIS; HEMORRHAGIC FEVER, EBOLA; METABOLISM; TREATMENT OUTCOME; VIRUS DISEASES;

ANIMALS; CURCUMIN; CYTOKINES; HEMORRHAGIC FEVER, EBOLA; HUMANS; TREATMENT OUTCOME; VIRUS DISEASES;

EID: 84921655875     PISSN: 0258851X     EISSN: 17917549     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Wauquier N, Becquart P, Padilla C, Baize S and Leroy EM: Human fatal Zaire Ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis. PloS Negl Trop Dis 4(10) http://dx.doi.org/10.1371/journal.pntd. 2010.0000837.
2. Villinger F, Rollin PE, Brar SS, Chikkala NF, Winter J, Sundstrom JB, Zaki SR, Swanepoel R, Ansari AA and Peters CJ: Markedly elevated levels of interferon (IFN)γ, IFNα, interleukin (IL)-2, IL10 and tumor necrosis factor-α associated with fatal Ebola virus infection. J Infect Dis 179: S188-S191, 1999.
3. Yuen KY and Wong SS: Human infection by avian influenza H5N1. Hong Kong Med J 11 : 189-199, 2005.
4. Haque A, Hober D and Kasper LH: Confronting potential influenza A (H5N1) pandemic with better vaccines. Emerg Infect Dis 13: 1512-1518, 2007.
5. Teijaro JR, Walsh KB, Rice S, Rosen H and Oldstone MBA: Mapping the innate signaling cascade essential for cytokine storm during influenza virus infection. Proc Natl Acad Sci 111: 3799-3804, 2014.
6. Huang KJ, Siu IJ, Theron M, Wu YC, Liu CC and Lei HY: An interferon-gamma related cytokine storm in SARS patients. J Med Virol 75: 185-194, 2005.
7. Imashuku S: Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagochytic lymphohistiocytosis. Crit. Rev Oncol Hematol 44: 259-272, 2002.
8. Harrison C: Sepsis: Calming the cytokine storm. Nature Rev Drug Discover 9: 360-361, 2010.
9. Clark IA, Alleva LM, Budd AC and Cowden WB: Understanding the role of inflammatory cytokines in malaria and related diseases. Travel Med Infect Dis 6 : 67-81, 2008.
10. Makhija R and Kingsnorth AN: Cytokine storm in acute pancreatitis. J. Hepatobiliary Pancreat Surg 9: 401-410, 2002.
11. Aikawa N: Cytokine storm in the pathogenesis of multiple organ dysfunction syndrome associated with surgical insults. Nihon Geka Gakkei Zasshi 97: 771-777, 1996.
12. Park WY, Goodman RB, Steinberg KP, Ruzinsky JT, Rudella F, Park DR, Pugin J, Skeritt SJ, Hudson LD and Martin TR: Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Amer J Resp Crit Care Med 164: 1896-1903, 2001.
13. St. Clair EW: The calm after the cytokine storm: Lessons from the TGN1412 trial. J Clin Invest 118: 1344-1347, 2008.
14. Abe Y, Hashimoto S and Horie T: Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol Res 39: 41-47, 1999.
15. Jain SK, Rains J, Croad J, Larson B and Jones K: Curcumin supplementation lowers TNFα, IL6, IL8, and MCP1 secretion in high glucose-treated cultured monocytes and blood levels of TNFα, IL6, MCP1, glucose, and glycosylated hemoglobin in diabetic rats. Antioxid Redox Signal 11 : 241-249, 2009.
16. Kloesch B, Becker T, Dietersdorfer E, Kiener H and Steiner G: Anti-inflammatory and apoptotic effects of the polyphenol curcumin on human fibroblast-like synoviocytes. Int Immunopharmacol 15 : 400-405, 2013.
17. Raflee P, Nelson VM, Manley S, Wellner M, Floer M, Binion DG and Shaker R: Effect of curcumin on acidic pH-induced expression of IL6 and IL8 in human esophageal epithelial cells (HET1A): Role of PKC, MAPKs, and NF?B. Amer J Physiol-Gastrointest Liver Physiol 296: G388-G398, 2009.
18. Biswas SK, McClure D, Jimenez LA, Megson IL and Rahman I: Curcumin induces glutathione biosynthesis and inhibits NF?B activation and interleukin-8 release in alveolar epithelial cells : Mechanism of free radical scavenging activity. Antioxid Redox Signal 7: 32-41, 2005.
19. Xu YX, Pindolia KR, Janakiraman N, Chapman RA and Gautam SC: Curcumin inhibits IL1α and TNFα induction of AP1 and NFκB DNA-binding activity in bone marrow stromal cells. Hematopathol Mol Hematol 11 : 49-62, 1997-1998.
20. Jobin C, Bradham CA, Russo MP, Juma B, Narula AS, Brenner DA and Sartor RB: Curcumin blocks cytokine-mediated NFκβ activation and proinflammatory gene expression by inhibiting inhibitory factor Iκβ kinase activity. J Immunol 163: 3474-3483, 1999.
21. Henrotin Y, Clutterbuck AL, Allaway D, Lodwig EM, Harris P, Mathy-Hartert M, Shakibaei M and Mobasheri A: Biological actions of curcumin on articular chondrocytes. Osteoarthr Cartil 18: 141-149, 2010.
22. Gao X, Kuo J, Jiang H, Deeb D, Liu Y, Divine G, Chapman RA, Dulchavsky SA and Gautam SC: Immunomodulatory activity of curcumin: Suppression of lymphocyte proliferation, development of cell-mediated cytotoxity, and cytokine production in vitro. Biochem Pharmacol 68: 51-61, 2004.
23. Fahey AJ, Robins RA and Constantinescu CS: Curcumin modulation of IFNβ and IL12 signaling and cytokine induction in human T-cells. J Cell Mol Med 11 : 1129-1137, 2007.
24. Bachmeier BE, Mohrenz IV, Mirisola V, Schleicher E, Romeo F, Hohneke C, Jochum M, Nerlich AG and Pfeffer U: Curcumin downregulates the inflammatory cytokines CXCL1 and -2 in breast cancer cells via NFkappaB. Carcinogenesis 29: 779-789, 2008.
25. Xiaoling MU, Jing Z, Fang X and Liangdan T: Curcumin inhibits invasion and metastasis in the human ovarian cancer cells SKOV3 by CXCL12-CXCR4 axis. Afr J Biotechnol 9: 8230-8234, 2010.
26. Xu YX, Pindolia KR, Janakiraman N, Noth CJ, Chapman RA and Gautam SC: Curcumin, a compound with anti-inflammatory and anti-oxidant properties, down regulates chemokine expression in bone marrow stromal cells. Exp Hematol 25 : 413-422, 1997.
27. Avasarala S, Zhang F, Liu G, Wang R, London SD and London L: Curcumin modulates the inflammatory response and inhibits subsequent fibrosis in a mouse model of viral-induced acute respiratory distress syndrome. PLoS ONE 8(2) http://dx.doi.org/10.1371/journal.pone. 2013.0057285.
28. Yu WG, Xu G, Ren GJ, Xu X, Yuan HQ, Qi XL and Tian KL: Preventive action of curcumin in experimental acute pancreatitis in mouse. Indian J Med Res 134: 717-724, 2011.
29. Cheppudira B, Greer A, Mares A, Fowler M, Garza T, Petz L, Loyd D and Clifford J: The anti-inflammatory and analgesic activity of curcumin in a rat model of full thickness thermal injury. J Pain 14: 552, 2013.
30. Song Y, Ge W, Cai H and Zwang H: Curcumin protects mice from coxsackie virus B3-induced myocarditis by inhibiting the phosphatidylinositol 3 kinase/Akt/nuclear factor-?B pathway. J Cardiovasc Pharmacol Ther 18: 560-569, 2013.
31. Moghadamtousi SZ, Kadir HA, Hassandarvish P, Tajik H, Abubakar S and Zandi K: A review on antibacterial, antiviral, and antifungal activity of curcumin Biomed Res Int 2014 http://dx.doi.org/10.1155/2014.186864.
32. Chen DY, Shien JH, Tiley L, Chiou SS, Wang SY, Chang TJ, Lee YJ, Chan KW and Hsu WL: Curcumin inhibits influenza virus infection and haemagglutination activity. Food Chem 119: 1346-1351, 2010.
33. Ou JL, Mizushina Y, Wang SY, Chuang DY, Nadar M and Hsu WL: Structure-activity relationship analysis of curcumin analogues on anti-influenza virus activity. FEBS J 280 : 5829-5840, 2013.
34. Chen CQ, Yu K, Yan QX, Xing CY, Chen Y, Yan Z, Shi YF, Zhao KW and Gao SM: Pure curcumin increases the expression of SOCS1 and SOCS3 in myeloproliferative neoplasms through suppressing class I histone deacetylases. Carcinogenesis 34: 1442-1449, 2013.
35. Kedzierski L, Linossi EM, Kolesnik TB, Day EB, Bird NL, Kile BT, Belz GT, Metcalf D, Nicola NA, Kedzierska K and Nicholson SE: Suppressor of cytokine signaling 4 (SOCS4) protects against severe cytokine storm and enhances viral clearance during influenza infection. PLoS Pathog 10(5) http://dx.doi.org/10:1371/journal.ppat.2014.1004134.
36. Ganjali S, Sahebkar A, Mahdipour E, Jamialahmadi K, Torabi S, Akhlaghi S, Ferns G, Parizadeh SMR and Ghayour-Mobarhan M: Investigation of the effects of curcumin on serum cytokines in obese individuals: A randomized controlled study. Sci World J 2014 http://dx.doi.org/10.1155/2014.898361.
37. Kobayashi T, Hashimoto S and Horie T: Curcumin inhibition of Dermatophagoides farinea-induced interleukin-5 (IL5) and granulocyte macrophage-colony stimulating factor (GM-CSF) production by lymphocytes from bronchial asthmatics. Biochem Pharmacol 54: 819-824, 1997.
38. Okamoto Y, Tanaka M, Fukui T and Masuzawa T: Inhibition of interleukin 17 production by curcumin in mice with collageninduced arthritis. Biomed Res 22 : 299-304, 2011.
39. Wang W, Zhu R, Xie Q, Li A, Xaio Y, Li K, Liu H, Cui D, Chen Y and Wang S: Enhanced bioavailability and efficiency of curcumin for the treatment of asthma by its formulation in solid lipid nanoparticles. Int J Nanomed 7 : 3667-3677, 2012.
40. Kondo A, Mogi M, Koshihara Y and Togani A: Signal transduction system for interleukin-6 and interleukin-11 synthesis stimulated by epinephrine in human osteoblasts and human osteogenic sarcoma cells. Biochem Pharmacol 61 : 319-326, 2001.